Scienture Holdings, Inc. (SCNX) stock
SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.99+0.09 (+3.10%)
Close on Nov 16, 2026Market cap $122.78MP/E –Yield –
Scienture EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Scienture's EPS for the twelve months ending Jun 30, 2026 was -$1.85. For fiscal 2025 it was -$2.70, down 208.9% from the year before. The highest annual figure on record is $2.48 in fiscal 2024.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.70 | -208.9% |
| FY2024 | Dec 31, 2024 | $2.48 | – |
| FY2023 | Dec 31, 2023 | -$23.35 | – |
| FY2022 | Dec 31, 2022 | -$6.13 | – |
| FY2021 | Dec 31, 2021 | -$9.75 | – |
| FY2020 | Dec 31, 2020 | -$4.95 | – |
| FY2019 | Dec 31, 2019 | -$0.75 | – |
| FY2018 | Dec 31, 2018 | $0.00 | -100.0% |
| FY2017 | Dec 31, 2017 | $0.90 | – |
| FY2016 | Dec 31, 2016 | -$8.10 | – |
| FY2015 | Dec 31, 2015 | -$3.60 | – |
| FY2014 | Dec 31, 2014 | -$6.30 | – |
| FY2013 | Dec 31, 2013 | -$13.50 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$0.07 | – |
| Q1 FY2026 | Mar 31, 2026 | -$0.08 | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.51 | – |
| Q3 FY2025 | Sep 30, 2025 | -$0.19 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.48 | -102.9% |
| Q1 FY2025 | Mar 31, 2025 | -$0.33 | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.34 | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.30 | – |
| Q1 FY2024 | Mar 31, 2024 | $16.77 | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.57 | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.90 | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.01 | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.49 | – |
| Q3 FY2022 | Sep 30, 2022 | -$0.91 | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.99 | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.80 | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.44 | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.40 | -900.0% |
| Q2 FY2021 | Jun 30, 2021 | -$4.80 | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.20 | -500.0% |
| Q4 FY2020 | Dec 31, 2020 | -$4.28 | – |
| Q3 FY2020 | Sep 30, 2020 | $0.30 | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.05 | -800.0% |
| Q1 FY2020 | Mar 31, 2020 | $0.30 | 0.0% |
| Q4 FY2019 | Dec 31, 2019 | -$1.32 | – |
| Q3 FY2019 | Sep 30, 2019 | $0.00 | – |
| Q2 FY2019 | Jun 30, 2019 | $0.15 | – |
| Q1 FY2019 | Mar 31, 2019 | $0.30 | – |
| Q3 FY2018 | Sep 30, 2018 | $0.00 | – |
| Q2 FY2018 | Jun 30, 2018 | $0.00 | – |
| Q1 FY2018 | Mar 31, 2018 | $0.00 | – |
| Q3 FY2017 | Sep 30, 2017 | $0.00 | – |
| Q2 FY2017 | Jun 30, 2017 | $0.00 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.00 | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.26 | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.70 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?